The FDA has published its final guidance on securing 510(k) clearance for peripheral vascular atherectomy devices. The document offers updated recommendations on the components of 510(k) submissions, including descriptive characteristics, biocompatibility, labeling, sterility, nonclinical, animal and clinical performance testing.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.